Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Language
Publication year range
1.
J Crit Care ; 51: 204-212, 2019 06.
Article in English | MEDLINE | ID: mdl-30903936

ABSTRACT

PURPOSE: During sepsis and mechanical ventilation oxidative stress is generated by endothelial and inflammatory lung cells. Our main objective was to study pulmonary NO (nitric oxide) production and nitroxidative stress in mechanically-ventilated septic patients. METHODS: We study 69 mechanically ventilated patients, 36 with sepsis and 33 without sepsis within the first 48 h of ICU admission compared with 33 mechanically ventilated patients without sepsis (MV) plus eight operating room patients without lung disease served as control healthy group (ORCG). Nitrite plus nitrate (NOx-), 3-nitrotyrosine and malondialdehyde (MDA) in bronchoalveolar lavage fluid (BALF) were analyzed. RESULTS: BALF NOx-, BALF 3-nitrotyrosine, BALF MDA, and plasma NOx- were higher in the Sepsis than in MV patients (all p < .05). Both SG and MV patients had higher BALF NOx- than the healthy control group (p < .001). In the Sepsis patients, the ICU non-survivors had higher levels of BALF NOx- than ICU survivors 80(70-127) µM versus 31(15-47) µM, p < .001. CONCLUSIONS: We conclude that during early phases of sepsis there is an enhanced lung nitroxidative stress due to an increase of NO production leading to secondary NO-derived oxidants, which promote protein nitration and lipid peroxidation.


Subject(s)
Nitric Oxide/metabolism , Oxidative Stress/physiology , Respiration, Artificial/adverse effects , Respiratory Insufficiency , Sepsis/complications , Adult , Aged , Bronchoalveolar Lavage Fluid , Case-Control Studies , Female , Humans , Male , Malondialdehyde/metabolism , Middle Aged , Pilot Projects , Respiratory Insufficiency/metabolism , Respiratory Insufficiency/therapy , Sepsis/metabolism
2.
Braz. j. med. biol. res ; 42(4): 305-311, Apr. 2009. ilus, tab
Article in English | LILACS | ID: lil-509174

ABSTRACT

Human serum albumin (HSA) is the most abundant protein in the intravascular compartment. It possesses a single thiol, Cys34, which constitutes ~80 percent of the total thiols in plasma. This thiol is able to scavenge plasma oxidants. A central intermediate in this potential antioxidant activity of human serum albumin is sulfenic acid (HSA-SOH). Work from our laboratories has demonstrated the formation of a relatively stable sulfenic acid in albumin through complementary spectrophotometric and mass spectrometric approaches. Recently, we have been able to obtain quantitative data that allowed us to measure the rate constants of sulfenic acid reactions with molecules of analytical and biological interest. Kinetic considerations led us to conclude that the most likely fate for sulfenic acid formed in the plasma environment is the reaction with low molecular weight thiols to form mixed disulfides, a reversible modification that is actually observed in ~25 percent of circulating albumin. Another possible fate for sulfenic acid is further oxidation to sulfinic and sulfonic acids. These irreversible modifications are also detected in the circulation. Oxidized forms of albumin are increased in different pathophysiological conditions and sulfenic acid lies in a mechanistic junction, relating oxidizing species to final thiol oxidation products.


Subject(s)
Humans , Serum Albumin/chemistry , Serum Albumin/metabolism , Sulfenic Acids/metabolism , Sulfhydryl Compounds/metabolism , Oxidation-Reduction , Protein Conformation , Sulfenic Acids/isolation & purification
3.
Braz J Med Biol Res ; 42(4): 305-11, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19330257

ABSTRACT

Human serum albumin (HSA) is the most abundant protein in the intravascular compartment. It possesses a single thiol, Cys34, which constitutes ~80% of the total thiols in plasma. This thiol is able to scavenge plasma oxidants. A central intermediate in this potential antioxidant activity of human serum albumin is sulfenic acid (HSA-SOH). Work from our laboratories has demonstrated the formation of a relatively stable sulfenic acid in albumin through complementary spectrophotometric and mass spectrometric approaches. Recently, we have been able to obtain quantitative data that allowed us to measure the rate constants of sulfenic acid reactions with molecules of analytical and biological interest. Kinetic considerations led us to conclude that the most likely fate for sulfenic acid formed in the plasma environment is the reaction with low molecular weight thiols to form mixed disulfides, a reversible modification that is actually observed in ~25% of circulating albumin. Another possible fate for sulfenic acid is further oxidation to sulfinic and sulfonic acids. These irreversible modifications are also detected in the circulation. Oxidized forms of albumin are increased in different pathophysiological conditions and sulfenic acid lies in a mechanistic junction, relating oxidizing species to final thiol oxidation products.


Subject(s)
Serum Albumin/chemistry , Serum Albumin/metabolism , Sulfenic Acids/metabolism , Sulfhydryl Compounds/metabolism , Humans , Oxidation-Reduction , Protein Conformation , Sulfenic Acids/isolation & purification
4.
Amino Acids ; 32(4): 543-51, 2007.
Article in English | MEDLINE | ID: mdl-17061035

ABSTRACT

Sulfenic acid (RSOH) is a central intermediate in both the reversible and irreversible redox modulation by reactive species of an increasing number of proteins involved in signal transduction and enzymatic pathways. In this paper we focus on human serum albumin (HSA), the most abundant plasma protein, proposed to serve antioxidant functions in the vascular compartment. Sulfenic acid in HSA has been previously detected using different methods after oxidation of its single free thiol Cys34 through one- or two-electron mechanisms. Since recent evidence suggests that sulfenic acid in HSA is stabilized within the protein environment, this derivative represents an appropriate model to examine protein sulfenic acid biochemistry, structure and reactivity. Sulfenic acid in HSA could be involved in mixed disufide formation, supporting a role of HSA-Cys34 as an important redox regulator in extracellular compartments.


Subject(s)
Free Radicals/metabolism , Serum Albumin/chemistry , Serum Albumin/metabolism , Sulfenic Acids/metabolism , Humans , Models, Molecular , Oxidants , Oxidation-Reduction , Protein Conformation , Sulfenic Acids/isolation & purification
5.
Arch Biochem Biophys ; 395(2): 225-32, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11697860

ABSTRACT

Peroxynitrite (PN), the product of the diffusion-limited reaction between nitric oxide (*NO) and superoxide (O*-(2)), represents a relevant mediator of oxidative modifications in low-density lipoprotein (LDL). This work shows for the first time the simultaneous action of low-controlled fluxes of PN and *NO on LDL oxidation in terms of lipid and protein modifications as well as oxidized lipid-protein adduct formation. Fluxes of PN (e.g., 1 microM min(-1)) initiated lipid oxidation in LDL as measured by conjugated dienes and cholesteryl ester hydroperoxides formation. Oxidized-LDL exhibited a characteristic fluorescent emission spectra (lambda(exc) = 365 nm, lambda(max) = 417 nm) in parallel with changes in both the free amino groups content and the relative electrophoretic mobility of the particle. Physiologically relevant fluxes of *NO (80-300 nM min(-1)) potently inhibited these PN-dependent oxidative processes. These results are consistent with PN-induced adduct formation between lipid oxidation products and free amino groups of LDL in a process prevented by the simultaneous presence of *NO. The balance between rates of PN and *NO production in the vascular wall will critically determine the final extent of LDL oxidative modifications leading or not to scavenger receptor-mediated LDL uptake and foam cell formation.


Subject(s)
Lipid Metabolism , Lipoproteins, LDL/metabolism , Nitric Oxide/metabolism , Peroxynitrous Acid/metabolism , Proteins/metabolism , Humans , Liposomes/metabolism , Models, Chemical , Oxygen/metabolism , Protein Binding , Time Factors
6.
Arch Biochem Biophys ; 384(2): 335-40, 2000 Dec 15.
Article in English | MEDLINE | ID: mdl-11368321

ABSTRACT

Copper binding to apolipoprotein B-100 (apo B-100) and its reduction by endogenous components of low-density lipoprotein (LDL) represent critical steps in copper-mediated LDL oxidation, where cuprous ion (Cu(I)) generated from cupric ion (Cu(II)) reduction is the real trigger for lipid peroxidation. Although the copper-reducing capacity of the lipid components of LDL has been studied extensively, we developed a model to specifically analyze the potential copper reducing activity of its protein moiety (apo B-100). Apo B-100 was isolated after solubilization and extraction from size exclusion-HPLC purified LDL. We obtained, for the first time, direct evidence for apo B-100-mediated copper reduction in a process that involves protein-derived radical formation. Kinetics of copper reduction by isolated apo B-100 was different from that of LDL, mainly because apo B-100 showed a single phase-exponential kinetic, instead of the already described biphasic kinetics for LDL (namely alpha-tocopherol-dependent and independent phases). While at early time points, the LDL copper reducing activity was higher due to the presence of alpha-tocopherol, at longer time points kinetics of copper reduction was similar in both LDL and apo B-100 samples. Electron paramagnetic resonance studies of either LDL or apo B-100 incubated with Cu(II), in the presence of the spin trap 2-methyl-2-nitroso propane (MNP), indicated the formation of protein-tryptophanyl radicals. Our results supports that apo B-100 plays a critical role in copper-dependent LDL oxidation, due to its lipid-independent-copper reductive ability.


Subject(s)
Apolipoproteins B/metabolism , Copper/metabolism , Apolipoprotein B-100 , Apolipoproteins B/isolation & purification , Chromatography, High Pressure Liquid , Electron Spin Resonance Spectroscopy , Free Radicals/metabolism , Humans , Kinetics , Lipoproteins, LDL/isolation & purification , Lipoproteins, LDL/metabolism , Nitroso Compounds/metabolism , Oxidation-Reduction , Spin Trapping , Tryptophan/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...